INTERNATIONAL PATENT: IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC., 宜明昂科生物医药技术（上海）股份有限公司 FILES APPLICATION FOR "TUMOR COMBINATION THERAPY TARGETING CTLA-4, PD-L1 AND VEGF"

GENEVA, Feb. 2 -- IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. (Building 15, Lane 1000, Zhangheng RoadPudong New Area, Shanghai 201203), 宜明昂科生物医药技术（上海）股份有限公司 (中国上海市浦东新区张衡路1000弄15号) filed a patent application (PCT/CN2025/109731) for "TUMOR COMBINATION THERAPY TARGETING CTLA-4, PD-L1 AND VEGF" on Jul 22, 2025. With publication no. WO/2026/021409, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classific...